BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Prostate cancer AND ELF4, MEF, 2000, ENSG00000102034, ELFR, RP3-510O21_2, Q99607 AND Diagnosis
8569 results:

  • 1. A Community-Based prostate cancer Screening and Education Program for Asian American Men in Medically Underserved Communities.
    Cho D; Gor B; Hwang H; Wang X; Hernandez M; Jones LA; Frost J; Roberson P; Pettaway CA
    Int J Environ Res Public Health; 2024 Mar; 21(4):. PubMed ID: 38673327
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. A population-based propensity score matching analysis of risk factors and the impact on survival associated with refusal of cancer-directed surgery in patients with prostate cancer.
    Tang Y; Gao Y; Zhang R; Li T; Yang Y; Huang L; Wei Y
    Sci Rep; 2024 Apr; 14(1):9494. PubMed ID: 38664545
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Comparing symptom clusters in cancer survivors by cancer diagnosis: A latent class profile analysis.
    Lee LJ; Han CJ; Saligan L; Wallen GR
    Support Care Cancer; 2024 Apr; 32(5):308. PubMed ID: 38662054
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Developing a Novel Enzalutamide-Resistant prostate cancer Model via AR F877L Mutation in LNCaP Cells.
    Wang R; Ma S; Xu N; Gan Y; Li P; Zhang J; Zhang Z; Gu Q; Xiang J
    Curr Protoc; 2024 Apr; 4(4):e1033. PubMed ID: 38652202
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. The role of urology and radiology in prostate biopsy: current trends and future perspectives.
    Mac Curtain BM; Temperley HC; Kelly JAO; Ryan J; Qian W; O'Sullivan N; Breen KJ; Mc Carthy CJ; Brennan I; Davis NF
    World J Urol; 2024 Apr; 42(1):249. PubMed ID: 38649544
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. [Construction of a model based on multipoint full-layer puncture biopsy for predicting pathological complete response after neoadjuvant therapy for locally advanced rectal cancer].
    Jin Y; Zhai ZW; Sun LT; Xia PD; Hu H; Jiang CQ; Zhao BC; Qu H; Qian Q; Dai Y; Yao HW; Wang ZJ; Han JG
    Zhonghua Wei Chang Wai Ke Za Zhi; 2024 Apr; 27(4):403-411. PubMed ID: 38644246
    [No Abstract]    [Full Text] [Related]  

  • 7. Racial and Ethnic Variation in Receipt and Intensity of Active Surveillance for Older Patients With Localized prostate cancer.
    Basourakos SP; An A; Davuluri M; Pinheiro LC; Al Awamlh BAH; Borregales LD; Luan D; Tamimi RM; Hu JC; Kensler KH
    Urol Pract; 2024 May; 11(3):538-546. PubMed ID: 38640417
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. [Application of 1470 nm semiconductor laser in the treatment of benign prostatic hyperplasia in ultra-aged patients].
    Wu D; Yi XM; Wei HX; Zhang KX; Shi CJ; Shi XQ; Xu ZY; Fu D
    Zhonghua Nan Ke Xue; 2023 Sep; 29(9):831-836. PubMed ID: 38639597
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. [Clinical study of artificial intelligence-guided image fusion assisted transperineal prostate biopsy].
    Hu J; Zhao XD; Zhou YL; Dong N; Ma MF; Chen YH; Sheng ZC; Dong J; He CQ; Xu S
    Zhonghua Nan Ke Xue; 2023 Aug; 29(8):729-735. PubMed ID: 38619521
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Do beta-blockers reduce negative intrusive thoughts and anxiety in cancer survivors? - An emulated trial.
    Ehrencrona C; Li Y; Angenete E; Haglind E; Franzén S; Grimby-Ekman A; Bock D
    BMC Cancer; 2024 Apr; 24(1):447. PubMed ID: 38605350
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. [A single center study:An analysis of the safety and validity of delaying repeated biopsy for patients with atypical small acinar proliferation].
    Ji WT; Liu DC; Cui WL; Hu Y; Wang Y; Tan JF
    Zhonghua Nan Ke Xue; 2023 May; 29(5):414-419. PubMed ID: 38602757
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Excess weight, weight gain, and prostate cancer risk and prognosis: the PROCA-life study.
    Støyten M; Knutsen T; Stikbakke E; Agledahl I; Wilsgaard T; Eggen AE; Richardsen E; Giovannucci E; Thune I; Haugnes HS
    Acta Oncol; 2024 Apr; 63():154-163. PubMed ID: 38591351
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Combination of prostate volume and apparent diffusion coefficient can stratify patients with a PI-RADS score of 3 to reduce unnecessary prostate biopsies.
    Dong Q; Wang C; Shen D; Ma Y; Zhang B; Xu S; Tao T; Xiao J
    Prostate; 2024 Jun; 84(8):780-787. PubMed ID: 38558415
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. The treatment landscape of nonmetastatic castrate resistant prostate cancer: A contemporary perspective.
    Yanada BA; Homewood D; Dias BH; Ogluszko C; Corcoran NM
    Urol Oncol; 2024 Jun; 42(6):175.e9-175.e18. PubMed ID: 38555235
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Critical survival periods in prostate cancer in Sweden explored by conditional survival analysis.
    Hemminki K; Zitricky F; Sundquist K; Sundquist J; Försti A; Hemminki A; Hemminki O
    Cancer Med; 2024 Apr; 13(7):e7126. PubMed ID: 38545829
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Machine-learning Algorithm-based Risk Prediction and Screening-detected prostate cancer in A Benign prostate Hyperplasia Cohort.
    Chang CC; Chiou JK; Lin CJ; Lu K; Li JR; Chang LW; Hung SC; Cheng CL
    Anticancer Res; 2024 Apr; 44(4):1683-1693. PubMed ID: 38537959
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. CD44 and CD133 protein expression might serve as a prognostic factor for early occurrence castration-resistant prostate cancer.
    Dwina Y; Zaid LSM; Saraswati M; Rachmadi L; Kekalih A; Rahadiani N; Louisa M; Agustina H; Mochtar CA; Hamid ARAH
    Prostate; 2024 Jun; 84(8):738-746. PubMed ID: 38528654
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. DNA methylation markers for risk of metastasis in a cohort of men with localized prostate cancer.
    Habeshian TS; Cannavale KL; Slezak JM; Shu YH; Chien GW; Chen X; Shi F; Siegmund KD; Van Den Eeden SK; Huang J; Chao CR
    Epigenetics; 2024 Dec; 19(1):2308920. PubMed ID: 38525786
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. DiagSet: a dataset for prostate cancer histopathological image classification.
    Koziarski M; Cyganek B; Niedziela P; Olborski B; Antosz Z; Żydak M; Kwolek B; Wąsowicz P; Bukała A; Swadźba J; Sitkowski P
    Sci Rep; 2024 Mar; 14(1):6780. PubMed ID: 38514661
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Adrenal-Permissive Germline HSD3B1 Allele and prostate cancer Outcomes.
    McKay RR; Nelson TJ; Pagadala MS; Teerlink CC; Gao A; Bryant AK; Agiri FY; Guram K; Thompson RF; Pridgen KM; Seibert TM; Lee KM; Carter H; Lynch JA; Hauger RL; Rose BS
    JAMA Netw Open; 2024 Mar; 7(3):e242976. PubMed ID: 38506808
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 429.